Ofloxacină Laropharm

Ofloxacin, the active ingredient in Ofloxacină Laropharm, is a fluoroquinolone antibiotic presented as a tablet for oral use. It treats a variety of bacterial infections in adults and children when prescribed by a healthcare professional.

GNH USA supplies Ofloxacină Laropharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ofloxacin is a broad‑spectrum antibacterial agent used to treat infections of several organ systems.

- Urinary tract infection: helps eradicate the causative bacteria and relieve symptoms. - Respiratory tract infection: aids in clearing bacterial pneumonia, bronchitis and sinusitis. - Skin and soft‑tissue infection: reduces bacterial load in cellulitis, abscesses and wound infections. - Eye infection (conjunctivitis): provides topical bacterial control when formulated for ocular use. - Sexually transmitted infection: treats uncomplicated gonorrhoea caused by susceptible strains.

Adverse reactions to ofloxacin may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Nausea: mild stomach upset that may improve with food. - Diarrhea: loose stools, occasionally watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness or unsteadiness. - Rash: mild skin erythema or itching. - Photosensitivity: increased skin reaction to sunlight.

Serious or Rare Side Effects: - Tendon rupture: sudden pain or loss of function, especially in the Achilles tendon. - QT interval prolongation: irregular heart rhythm detectable on ECG. - Severe allergic reaction: swelling, hives, or difficulty breathing. - Peripheral neuropathy: tingling, numbness or weakness in extremities. - Hepatotoxicity: abnormal liver enzymes or jaundice. - Clostridioides difficile infection: severe diarrhea following antibiotic use.

Before initiating therapy with ofloxacin, consider the following safety measures:

- Renal impairment: adjust dose in patients with reduced kidney function. - Hepatic impairment: use cautiously in liver disease. - History of tendon disorders: avoid in patients with prior tendon injury. - Cardiac risk: monitor ECG in patients with known QT prolongation. - Pregnancy and lactation: contraindicated unless benefits outweigh risks. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Ofloxacin can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce absorption of ofloxacin. - Warfarin: may increase anticoagulant effect and bleeding risk. - Cyclosporine: increased risk of tendon toxicity.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may heighten CNS stimulation. - Theophylline: plasma levels may rise, leading to toxicity. - Oral hypoglycemics: ofloxacin can enhance glucose‑lowering effect.